Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004951441 | SCV005544486 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-07-27 | criteria provided, single submitter | clinical testing | The p.K29R variant (also known as c.86A>G), located in coding exon 1 of the BLM gene, results from an A to G substitution at nucleotide position 86. The lysine at codon 29 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |
Natera, |
RCV001279093 | SCV001466154 | uncertain significance | Bloom syndrome | 2020-04-23 | no assertion criteria provided | clinical testing |